MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
NCT06212466
·
clinicaltrials.gov ↗
COMPLETED
Status
136
Enrollment
INDUSTRY
Sponsor class
Conditions
Ischemic Heart Disease
Coronary Microvascular Disease
Angina
Myocardial Ischemia
Interventions
DEVICE:
CardioFlux
Sponsor
Genetesis Inc.